Table 1.
Patient's characteristics (n = 74). Age and PSA are presented in years and ng/ml, respectively.
| ISUP/WHO grade groups* (n = 74) | |
|---|---|
| 1 | 1 (1%) |
| 2 | 6 (8%) |
| 3 | 14 (19%) |
| 4 | 24 (33%) |
| 5 | 29 (39%) |
| pT stadium (n = 74) | |
| pT2 | 22 (30%) |
| pT3 | 51 (69%) |
| pT4 | 1 (1%) |
| pN stadium (n = 74) | |
| pN0 | 44 (59%) |
| pN1 | 30 (41%) |
| At RPE (n = 74) | |
| Age median (IQR) | 65 (60-70) |
| PSA median (IQR) | 12 (7-19) |
| <10 | 33 (45%) |
| 10-20 | 23 (31%) |
| >20 | 18 (24%) |
| At 68Ga-PSMA-11 PET scan time point (n = 120)** | |
| Age median (IQR) | 69 (65-73) |
| ADT | 17 (14%) |
| PSA median (IQR) | 0.99 (0.32-4.27) |
| ≤0.5 | 42 (35%) |
| 0.5-10 | 59 (49%) |
| ≥10 | 19 (16%) |
*from radical prostatectomy (RPE) specimen
**34 patients had two or three 68Ga-PSMA-11 PET scans